The Europe Veterinary Healthcare Market is projected to grow significantly, reaching an estimated US$ 43,533.0 million by 2031, up from US$ 27,141.7 million in 2024, reflecting a compound annual growth rate (CAGR) of 7.1% from 2025 to 2031. This growth is driven by several factors, including increased investments in research and development, the establishment of more diagnostic laboratories, and a heightened awareness of animal health.
Key countries in this market include France, Germany, the UK, Italy, Spain, and other regions in Europe. Established players in the veterinary diagnostics sector are enhancing their presence, which is crucial for the market's expansion. The rise in diagnostic laboratories is pivotal for early disease detection and monitoring, which is essential for effective disease management. The growing incidence of zoonotic diseases—such as salmonellosis, listeriosis, and campylobacteriosis—alongside vector-borne diseases like West Nile virus and tick-borne encephalitis, underscores the need for accurate diagnostic solutions, further propelling market growth.
### Market Segmentation
Over the last decade, there has been a notable shift in the perception of animal health, recognizing it as vital for animal welfare, public health, food security, and economic stability. The Food and Agriculture Organization (FAO) emphasizes that healthy livestock is crucial for sustainable food systems, which drives the adoption of pharmaceuticals to prevent diseases like foot-and-mouth disease, brucellosis, and avian influenza. Global organizations such as the WHO and WOAH have initiated campaigns to raise awareness about the importance of vaccination in controlling zoonotic diseases. The WHO's Global Strategic Plan aims to eliminate human deaths from dog-mediated rabies by 2030, promoting large-scale vaccine adoption.
The increasing availability of information on animal health through digital platforms and public campaigns is enhancing the adoption of veterinary healthcare products, including pharmaceuticals and medical devices. Social media and online resources empower pet owners and farmers to understand the risks associated with preventable diseases, including zoonotic diseases like rabies and leptospirosis. Collaborations and funding from animal welfare organizations are boosting the production and distribution of new vaccines and diagnostic tools. The "Roadmap to Reducing the Need for Antibiotics" program, launched by Health for Animals in 2019, has seen significant investments aimed at developing new vaccines and diagnostics, as well as educating users on responsible practices. This initiative aims to introduce 71 new vaccines and 28 diagnostic tools by 2025, enhancing disease management capabilities.
### Country Insights
By country, Germany holds the largest share of the Europe Veterinary Healthcare Market in 2024. The country is renowned for its production of pork, beef, and poultry, playing a significant role in both domestic consumption and export. The livestock sector is crucial for Germany's economy, with a notable increase in poultry production. In 2023, poultry consumption in Germany reached approximately 1.678 million tonnes, reflecting a growing demand for high-quality, disease-free meat and dairy products. This demand drives farmers to implement vaccination programs to ensure animal health and compliance with food safety standards.
In January 2025, Brandenburg, Germany, announced the activation of its FMD vaccine bank, which is essential for producing vaccines for livestock within a week, highlighting the proactive measures taken to safeguard animal health.
### Key Players
The Europe Veterinary Healthcare Market features several key players, including Merck & Co., Inc., Boehringer Ingelheim International GmbH, Ceva Santé Animale, Zoetis Inc, Elanco Animal Health Inc, Idexx Laboratories Inc, Neogen Corp, HIPRA SA, Shenzhen Mindray Animal Medical Technology Co., LTD, and Antech Diagnostics, Inc. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to consumers.
Key countries in this market include France, Germany, the UK, Italy, Spain, and other regions in Europe. Established players in the veterinary diagnostics sector are enhancing their presence, which is crucial for the market's expansion. The rise in diagnostic laboratories is pivotal for early disease detection and monitoring, which is essential for effective disease management. The growing incidence of zoonotic diseases—such as salmonellosis, listeriosis, and campylobacteriosis—alongside vector-borne diseases like West Nile virus and tick-borne encephalitis, underscores the need for accurate diagnostic solutions, further propelling market growth.
### Market Segmentation
The Europe Veterinary Healthcare Market is segmented by various criteria:
- **Animal Type**: The market is divided into Companion Animals and Livestock & Poultry, with Livestock & Poultry holding the largest market share in 2024.
- **Companion Animal Type**: This segment includes Dogs, Cats, and Others, where Dogs represent the largest share.
- **Livestock and Poultry**: This includes Poultry, Equine, Bovine, and Others, with Poultry again leading the market.
- **Product Type**: The market is categorized into Pharmaceuticals, Medical Devices, and Feed Additives, with Pharmaceuticals dominating the market.
- **Pharmaceutical Products**: This includes Antimicrobials, Parasiticides, Vaccines, and Others, where the 'Others' category held the largest share in 2024.
- **End User**: The market is segmented into Veterinary Hospitals, Clinics, and Others, with Veterinary Hospitals leading in market share.
Over the last decade, there has been a notable shift in the perception of animal health, recognizing it as vital for animal welfare, public health, food security, and economic stability. The Food and Agriculture Organization (FAO) emphasizes that healthy livestock is crucial for sustainable food systems, which drives the adoption of pharmaceuticals to prevent diseases like foot-and-mouth disease, brucellosis, and avian influenza. Global organizations such as the WHO and WOAH have initiated campaigns to raise awareness about the importance of vaccination in controlling zoonotic diseases. The WHO's Global Strategic Plan aims to eliminate human deaths from dog-mediated rabies by 2030, promoting large-scale vaccine adoption.
The increasing availability of information on animal health through digital platforms and public campaigns is enhancing the adoption of veterinary healthcare products, including pharmaceuticals and medical devices. Social media and online resources empower pet owners and farmers to understand the risks associated with preventable diseases, including zoonotic diseases like rabies and leptospirosis. Collaborations and funding from animal welfare organizations are boosting the production and distribution of new vaccines and diagnostic tools. The "Roadmap to Reducing the Need for Antibiotics" program, launched by Health for Animals in 2019, has seen significant investments aimed at developing new vaccines and diagnostics, as well as educating users on responsible practices. This initiative aims to introduce 71 new vaccines and 28 diagnostic tools by 2025, enhancing disease management capabilities.
### Country Insights
By country, Germany holds the largest share of the Europe Veterinary Healthcare Market in 2024. The country is renowned for its production of pork, beef, and poultry, playing a significant role in both domestic consumption and export. The livestock sector is crucial for Germany's economy, with a notable increase in poultry production. In 2023, poultry consumption in Germany reached approximately 1.678 million tonnes, reflecting a growing demand for high-quality, disease-free meat and dairy products. This demand drives farmers to implement vaccination programs to ensure animal health and compliance with food safety standards.
In January 2025, Brandenburg, Germany, announced the activation of its FMD vaccine bank, which is essential for producing vaccines for livestock within a week, highlighting the proactive measures taken to safeguard animal health.
### Key Players
The Europe Veterinary Healthcare Market features several key players, including Merck & Co., Inc., Boehringer Ingelheim International GmbH, Ceva Santé Animale, Zoetis Inc, Elanco Animal Health Inc, Idexx Laboratories Inc, Neogen Corp, HIPRA SA, Shenzhen Mindray Animal Medical Technology Co., LTD, and Antech Diagnostics, Inc. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to consumers.
Table of Contents
1. Introduction
2. Executive Summary
3. Research Methodology
4. Veterinary Healthcare Market Landscape
5. Europe Veterinary Healthcare Market - Key Market Dynamics
6. Veterinary Healthcare Market - Europe Market Analysis
7. Europe Veterinary Healthcare Market Revenue Analysis - by Animal Type
8. Europe Veterinary Healthcare Market Revenue Analysis - by Companion Animal Type
9. Europe Veterinary Healthcare Market Revenue Analysis - by Livestock and Poultry
10. Europe Veterinary Healthcare Market Revenue Analysis - by Product Type
11. Europe Veterinary Healthcare Market Revenue Analysis - by Pharmaceuticals Products
12. Europe Veterinary Healthcare Market Revenue Analysis - by End User
13. Europe Veterinary Healthcare Market - Country Analysis
14 Competitive Landscape
15 Industry Landscape
16 COMPANY PROFILES
17. Appendix
LIST OF TABLES
LIST OF FIGURES
Companies
The List of Companies - Europe Veterinary Healthcare MarketMerck & Co Inc
Boehringer Ingelheim International GmbH
Ceva Santé Animale
Zoetis Inc
Elanco Animal Health Inc
Idexx Laboratories Inc
Neogen Corp
HIPRA SA
Shenzhen Mindray Animal Medical Technology Co., LTD
Antech Diagnostics, Inc
